Journal Article Summary
The article investigates the effectiveness and side effects of two long-acting medications for attention-deficit/hyperactivity disorder (ADHD): extended-release dexmethylphenidate (ER d-MPH) and extended-release mixed amphetamine salts (ER MAS). Understanding how different doses of these medications impact ADHD symptoms is important because it can help guide treatment decisions for children and adolescents struggling with this condition. By comparing these two medications, the study aims to provide insights into their relative effectiveness and potential side effects, which can significantly affect patients' quality of life.
In this study, 56 children and adolescents diagnosed with ADHD participated in an 8-week trial that involved both medications in a double-blind, crossover design. Participants were given different doses of ER d-MPH and ER MAS, along with a placebo, to assess their effectiveness in reducing ADHD symptoms. The results showed that both medications significantly reduced symptoms, particularly hyperactivity and impulsivity, with higher doses leading to better outcomes. However, improvements in inattentive symptoms were less strongly linked to dose increases. Notably, around 80% of participants showed significant improvement at the highest dose of ER MAS, while a similar percentage responded well to ER d-MPH.
Despite these promising findings, the study has limitations, including a relatively small sample size and the short duration of the trial. Additionally, some patients responded better to one medication over the other, indicating that individual responses can vary. Patients and caregivers should discuss these results with healthcare professionals to understand the best treatment options for ADHD, considering both the effectiveness and potential side effects of these medications. It is essential to tailor ADHD treatment to each individual's needs, taking into account how they respond to different medications and doses.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Stein Mark A., Waldman Irwin D., Charney Elizabeth, Aryal Subhash, Sable Craig, Gruber Reut, Newcorn Jeffrey H.. Dose Effects and Comparative Effectiveness of Extended Release Dexmethylphenidate and Mixed Amphetamine Salts. Journal of Child and Adolescent Psychopharmacology 2011. DOI: 10.1089/cap.2011.0018. PMID: 22136094. PMCID: PMC3243461.
Featured Pill Pals Product
Atomoxetine 60 mg Capsules --- Generic for Strattera --- Glenmark
Atomoxetine 60 mg Capsules — Generic for Strattera — Glenmark is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
